Patienter, der fik Cholestagel i kliniske undersøgelser, havde mindre tendens til flatulens (luft i maven) og diarré end patienter, som fik placebo (inaktiv tablet).
Patients receiving Cholestagel in clinical studies were less likely to suffer flatulence (wind) and diarrhoea as patients receiving placebo (inactive tablet).